![Medtronic PROTECTA XT DR D314DRG Скачать руководство пользователя страница 42](http://html.mh-extra.com/html/medtronic/protecta-xt-dr-d314drg/protecta-xt-dr-d314drg_clinician-manual_1763148042.webp)
EnTrust clinical study – This clinical study, which evaluated the safety and clinical
performance of the EnTrust ICD system, provides support for the Protecta XT DR Model
D314DRG devices.
EnTrust tachyarrhythmia detection performance vs. GEM DR tachyarrhythmia
detection performance – This retrospective evaluation of the EnTrust detection algorithm
was performed on spontaneous rhythms recorded in patients implanted with the GEM DR
ICD. It provided support for the modifications made to the PR Logic Sinus Tachycardia
criterion in the EnTrust devices. These modifications also apply to the Protecta XT DR Model
D314DRG devices.
FAST study – This clinical study, which evaluated the OptiVol Fluid Monitoring feature in
InSync Marquis devices to corroborate the MIDHeFT clinical data, provides support for the
OptiVol Fluid Monitoring feature in Protecta XT DR Model D314DRG devices.
GEM DR clinical studies – This clinical study, which evaluated the appropriateness of dual
chamber sensing and tachyarrhythmia detection during induced and simulated cardiac
arrhythmias in GEM DR devices, provides support for the Protecta XT DR Model D314DRG
devices.
GEM III DR Model 7275 MVP study – This clinical study, which evaluated the performance
of MVP mode pacing in the GEM III DR Model 7275 devices, provides support for MVP
mode in the Protecta XT DR Model D314DRG devices.
InSync III Marquis clinical study – This clinical study, which evaluated the Conducted
AF Response feature in the InSync III Marquis devices, provides support for Conducted AF
Response in Protecta XT DR Model D314DRG devices.
Jewel AF clinical study for AF patients only – This clinical study evaluated the atrial
tachyarrhythmia therapies and dual chamber tachyarrhythmia detection algorithm provided
by Jewel AF Model 7250 devices. The patients included in the study had a primary indication
of atrial fibrillation or atrial flutter. It provides support for atrial tachyarrhythmia therapies and
dual chamber tachyarrhythmia detection in the Protecta XT DR Model D314DRG devices.
Jewel AF clinical study for VT/AT patients – This clinical study evaluated the atrial
tachyarrhythmia therapies and dual chamber tachyarrhythmia detection algorithm provided
by Jewel AF Model 7250 devices. The patients included in the study had a primary indication
of ventricular tachyarrhythmia. Some of the patients in the study also had a history of atrial
tachyarrhythmia. This clinical study provides support for atrial tachyarrhythmia therapies
and dual chamber tachyarrhythmia detection in the Protecta XT DR Model D314DRG
devices.
Kappa 700 clinical study – This study, which evaluated the safety and clinical
performance of the Kappa 700 pacemakers, provides support for the Right Ventricular
Capture Management feature and other bradycardia pacing features.
Medtronic
PROTECTA™ XT DR D314DRG
42
Clinician Manual
Содержание PROTECTA XT DR D314DRG
Страница 2: ......
Страница 9: ...Index 488 Medtronic PROTECTA XT DR D314DRG Clinician Manual 9 ...
Страница 506: ......
Страница 507: ......